- Raw materials
- Ophthalmic Agents
- Guaiazulen
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Guaiazulene (Guaiazulen) API Manufacturers & Suppliers
1 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
Employees: 50+
All certificates
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Guaiazulen | CAS No: 489-84-9 | GMP-certified suppliers
A medication that is an experimental sesquiterpene compound investigated for potential applications in ophthalmological conditions requiring further clinical evaluation.
Therapeutic categories
Product Snapshot
- Guaiazulen is available in oral dosage forms including capsules and gels
- It is primarily investigated for anti-inflammatory and dermatological applications
- The compound is currently in an experimental stage with no approved status by major regulatory agencies
Clinical Overview
Currently, guaiazulen is designated as an experimental compound and does not have established clinical indications or approved therapeutic uses. It has been noted in the context of ophthalmological research, although detailed pharmacodynamic and pharmacokinetic profiles remain limited or unreported in the literature.
The mechanism of action of guaiazulen has not been definitively characterized. Information regarding its absorption, distribution, metabolism, and excretion (ADME) parameters is similarly unavailable, which limits comprehensive understanding of its behavior in biological systems.
Safety and toxicity data have not been well documented at this stage. Any experimental or clinical evaluations should proceed with caution, adhering to regulatory guidelines for investigational substances.
Notable pharmaceutical brands or marketed formulations containing guaiazulen are not currently recognized, reflecting its status as a compound under investigation rather than an approved therapeutic agent.
From an API procurement perspective, sourcing guaiazulen requires careful verification of chemical purity and compliance with applicable regulatory standards. Reliable suppliers should provide documentation of manufacturing processes, provenance, and quality control testing to ensure batch consistency suitable for research or development purposes. Given its experimental designation, attention to synthesis pathways, impurity profiles, and stability characteristics is essential to support downstream formulation and regulatory activities.
Identification & chemistry
| Generic name | Guaiazulen |
|---|---|
| Molecule type | Small molecule |
| CAS | 489-84-9 |
| UNII | 2OZ1K9JKQC |
| DrugBank ID | DB13329 |
Formulation & handling
- Guaiazulen is a small molecule intended for oral administration primarily in capsule and gel forms.
- Its high logP value indicates significant lipophilicity, suggesting potential formulation challenges related to bioavailability.
- Low aqueous solubility may necessitate solubilization strategies to enhance dissolution and absorption in oral formulations.
Regulatory status
Guaiazulen is a type of Ophthalmic Agents
Ophthalmic agents belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category specifically designed for ophthalmic applications. These agents are formulated to treat various eye conditions and disorders. Ophthalmic agents encompass a wide range of medications, including eye drops, ointments, gels, and intraocular implants.
These agents are developed to address specific therapeutic needs related to the eyes, such as reducing intraocular pressure in glaucoma, treating inflammation and infection, relieving dryness and itching, and managing allergies. They may also be used to dilate the pupils during diagnostic procedures or surgeries.
Ophthalmic agents are formulated with precise concentrations of active ingredients to ensure efficacy and safety. Common classes of ophthalmic agents include beta-blockers, prostaglandin analogs, carbonic anhydrase inhibitors, corticosteroids, and antihistamines.
When administering ophthalmic agents, it is crucial to follow proper application techniques to ensure optimal drug delivery and minimize side effects. Eye drops, for example, are typically applied as a gentle instillation into the conjunctival sac, while ointments are applied along the lower eyelid.
These pharmaceutical API ophthalmic agents undergo rigorous quality control and regulatory scrutiny to meet industry standards and ensure patient safety. Manufacturers must comply with Good Manufacturing Practices (GMP) and adhere to stringent quality assurance protocols.
Overall, ophthalmic agents play a vital role in the management and treatment of various eye conditions, providing patients with targeted relief and improving ocular health. It is important to consult with a healthcare professional to determine the appropriate ophthalmic agent for individual needs and to receive proper guidance on usage and potential side effects.
Guaiazulen API manufacturers & distributors
Compare qualified Guaiazulen API suppliers worldwide. We currently have 1 companies offering Guaiazulen API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| Sinoway industrial Co.,Lt... | Distributor | China | China | CoA | 757 products |
When sending a request, specify which Guaiazulen API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality Guaiazulen API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
